Phase Initial 4 weeks Daily Dose 300 mcg Volume 0.18 mL Units (U-100) 18 units Phase Maintenance (weeks 5-12) Daily Dose 500 mcg Volume 0.30 mL Units (U-100) 30 units Phase Optional extension Daily Dose 300-500 mcg Volume 0.18-0.30 mL Units (U-100) 18-30 units This summarizes the published research-context dose range (commonly cited 300-500 mcg/day)
Read article Price list 10 min read Research Peptide Pricing Comparison A catalog-focused pricing comparison for research peptide records, built around public price, offered size, molecule class, category, checkout path, shipping, returns, and RUO boundaries
evaluated GHK-Cu eye cream in 41 women with photodamage, finding 55% reduction in periorbital wrinkles
Dark Spots Serum
The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance